{
    "table_name": "CLINICAL_CPTAC_TCGA_PDC_V1_17",
    "table_fullname": "TCGA_MITELMAN.TCGA_VERSIONED.CLINICAL_CPTAC_TCGA_PDC_V1_17",
    "column_names": [
        "vital_status",
        "days_to_death",
        "primary_site",
        "ajcc_pathologic_m",
        "hiv_positive",
        "prior_treatment",
        "days_to_hiv_diagnosis",
        "ldh_normal_range_upper",
        "project_submitter_id",
        "hpv_positive_type",
        "year_of_death",
        "morphology",
        "days_to_last_known_disease_status",
        "ethnicity",
        "site_of_resection_or_biopsy",
        "days_to_new_event",
        "new_event_anatomic_site",
        "hpv_status",
        "ajcc_pathologic_t",
        "tissue_or_organ_of_origin",
        "ldh_level_at_diagnosis",
        "year_of_birth",
        "age_at_diagnosis",
        "disease_type",
        "figo_stage",
        "diagnosis_id",
        "gender",
        "demographic_id",
        "lymph_nodes_positive",
        "days_to_last_follow_up",
        "case_submitter_id",
        "circumferential_resection_margin",
        "demographic_submitter_id",
        "ajcc_pathologic_stage",
        "race",
        "new_event_type",
        "year_of_diagnosis",
        "days_to_birth",
        "prior_malignancy",
        "tumor_stage",
        "ajcc_pathologic_n",
        "primary_diagnosis",
        "case_id",
        "colon_polyps_history",
        "diagnosis_submitter_id"
    ],
    "column_types": [
        "TEXT",
        "NUMBER",
        "TEXT",
        "TEXT",
        "TEXT",
        "BOOLEAN",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "NUMBER",
        "TEXT",
        "NUMBER",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "NUMBER",
        "NUMBER",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "NUMBER",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "NUMBER",
        "BOOLEAN",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT",
        "TEXT"
    ],
    "description": [
        "The survival state of the person registered on the protocol",
        "Number of days between the date used for index and the date from a person's date of death represented as a calculated number of days",
        "The text term used to describe the general location of the malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O)",
        "Code to represent the defined absence or presence of distant spread or metastases (M) to locations via vascular channels or lymphatics beyond the regional lymph nodes, using criteria established by the American Joint Committee on Cancer (AJCC)",
        "Text term to signify whether a physician has diagnosed HIV infection in a patient",
        "A yes/no/unknown/not applicable indicator related to the administration of therapeutic agents received before the body specimen was collected",
        "Time interval from the date of the initial pathologic diagnosis to the date of human immunodeficiency diagnosis, represented as a calculated number of days",
        "The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for lactate dehydrogenase (units not specified)",
        "Project Submitter ID (e.g. PJ25730263, Georgetown Lung Cancer Proteomics Study)",
        "Text classification to represent the strain or type of human papillomavirus identified in an individual",
        "Numeric value to represent the year of the death of an individual",
        "The third edition of the International Classification of Diseases for Oncology, published in 2000 used principally in tumor and cancer registries for coding the site (topography) and the histology (morphology) of neoplasms. The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs. In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains. A system of numbered categories for representation of data",
        "Time interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days",
        "An individual's self-described social and cultural grouping, specifically whether an individual describes themselves as Hispanic or Latino, based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau",
        "The text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O)",
        "Time interval from the date of new tumor event including progression, recurrence and new primary malignancies to the date of initial pathologic diagnosis, represented as a calculated number of days",
        "Text term to specify the anatomic location of the return of tumor after treatment",
        "The findings of the oncogenic HPV",
        "Code of pathological T (primary tumor) to define the size or contiguous extension of the primary tumor (T), using staging criteria from the American Joint Committee on Cancer (AJCC)",
        "The text term used to describe the anatomic site of origin, of the patient's malignant disease, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O)",
        "The 2 decimal place numeric laboratory value measured, assigned or computed related to the assessment of lactate dehydrogenase in a specimen",
        "Numeric value to represent the calendar year in which an individual was born",
        "Age at the time of diagnosis expressed in number of days since birth",
        "The text term used to describe the type of malignant disease, as categorized by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O)",
        "The extent of a cervical or endometrial cancer within the body, especially whether the disease has spread from the original site to other parts of the body, as described by the International Federation of Gynecology and Obstetrics (FIGO) stages",
        "Unique identifier for data from the investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation (e.g. e8dd475b-693a-11ea-b1fd-0aad30af8a83)",
        "Text designations that identify gender; identification is self-reported and may come from a form, questionnaire, interview, etc.",
        "Unique identifier attributed to data for the characterization of the patient by means of segmenting the population--for instance, characterization by age, sex, or race (e.g. 848b480c-0f56-11e9-a064-0a9c39d33490)",
        "The number of lymph nodes involved with disease as determined by pathologic examination",
        "Time interval from the date of last follow up to the date of initial pathologic diagnosis, represented as a calculated number of days",
        "Unique identifier deriving from the data submitter that is associated with a specific patient (e.g. 05BR016)",
        "Numeric value used to describe the non-peritonealised bare area of rectum, comprising anterior and posterior segments, when submitted as a surgical specimen resulting from excision of cancer of the rectum",
        "Unique identifier deriving from data submitter that is attributed to data for the characterization of the patient by means of segmenting the population (e.g., characterization by age, sex, or race) (e.g. P001-DM)",
        "The extent of a cancer, especially whether the disease has spread from the original site to other parts of the body based on AJCC staging criteria",
        "An arbitrary classification of a taxonomic group that is a division of a species; the provided values are based on the categories defined by the U.S. Office of Management and Business and used by the U.S. Census Bureau",
        "Text term to identify a new tumor event",
        "Numeric value to represent the year of an individual's initial pathologic diagnosis of cancer",
        "Number of days between the date used for index and the date from a person's date of birth represented as a calculated negative number of days",
        "The yes/no/unknown indicator used to describe the patient's history of prior cancer diagnosis",
        "The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body. The accepted values for tumor_stage depend on the tumor site, type, and accepted staging system. These items should accompany the tumor_stage value as associated metadata",
        "The codes that represent the stage of cancer based on the nodes present (N stage) according to criteria based on multiple editions of the AJCC's Cancer Staging Manual",
        "Text term used to describe the patient's histologic diagnosis, as described by the World Health Organization's (WHO) International Classification of Diseases for Oncology (ICD-O)",
        "Unique identifier associated with a specific patient (e.g. 24cb0fcb-63d6-11e8-bcf1-0a2705229b82)",
        "Yes/No indicator to describe if the subject had a previous history of colon polyps as noted in the history/physical or previous endoscopic report (s)",
        "Unique identifier deriving from data submitter attributed to data from the investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation (e.g. 33-DX)"
    ],
    "sample_rows": [
        {
            "case_id": "6a47870c-ec51-11e9-81b4-2a2ae2dbcce4",
            "case_submitter_id": "OVARIAN-CONTROL",
            "project_submitter_id": "CPTAC-TCGA",
            "primary_site": null,
            "disease_type": "Other",
            "demographic_id": "1f061f27-f645-11e9-9a07-0a80fada099c",
            "demographic_submitter_id": "OVARIAN-CONTROL-DM",
            "race": null,
            "ethnicity": null,
            "gender": null,
            "days_to_birth": NaN,
            "days_to_death": NaN,
            "year_of_birth": NaN,
            "year_of_death": NaN,
            "vital_status": null,
            "diagnosis_id": "87232c66-f649-11e9-9a07-0a80fada099c",
            "diagnosis_submitter_id": "OVARIAN-CONTROL-DX",
            "primary_diagnosis": null,
            "age_at_diagnosis": NaN,
            "year_of_diagnosis": null,
            "days_to_hiv_diagnosis": null,
            "days_to_last_follow_up": NaN,
            "days_to_last_known_disease_status": null,
            "days_to_new_event": null,
            "ajcc_pathologic_m": null,
            "ajcc_pathologic_n": null,
            "ajcc_pathologic_stage": null,
            "ajcc_pathologic_t": null,
            "circumferential_resection_margin": null,
            "colon_polyps_history": null,
            "figo_stage": null,
            "hiv_positive": null,
            "hpv_positive_type": null,
            "hpv_status": null,
            "ldh_level_at_diagnosis": null,
            "ldh_normal_range_upper": null,
            "lymph_nodes_positive": null,
            "morphology": null,
            "new_event_anatomic_site": null,
            "new_event_type": null,
            "prior_malignancy": null,
            "prior_treatment": null,
            "site_of_resection_or_biopsy": null,
            "tissue_or_organ_of_origin": null,
            "tumor_stage": null
        },
        {
            "case_id": "3b72a8e5-63d7-11e8-bcf1-0a2705229b82",
            "case_submitter_id": "TCGA-13-1410",
            "project_submitter_id": "CPTAC-TCGA",
            "primary_site": "Ovary",
            "disease_type": "Ovarian Serous Cystadenocarcinoma",
            "demographic_id": "f69a92b3-7588-11e8-bcf1-0a2705229b82",
            "demographic_submitter_id": "TCGA-13-1410-DM",
            "race": "White",
            "ethnicity": "Not Hispanic or Latino",
            "gender": "Female",
            "days_to_birth": -20950.0,
            "days_to_death": NaN,
            "year_of_birth": 1951.0,
            "year_of_death": NaN,
            "vital_status": "Alive",
            "diagnosis_id": "ff2ca176-70ca-11e8-bcf1-0a2705229b82",
            "diagnosis_submitter_id": "TCGA-13-1410-DX",
            "primary_diagnosis": "Serous cystadenocarcinoma, NOS",
            "age_at_diagnosis": 20950.0,
            "year_of_diagnosis": "2008",
            "days_to_hiv_diagnosis": "--",
            "days_to_last_follow_up": 2464.0,
            "days_to_last_known_disease_status": null,
            "days_to_new_event": "--",
            "ajcc_pathologic_m": null,
            "ajcc_pathologic_n": null,
            "ajcc_pathologic_stage": null,
            "ajcc_pathologic_t": null,
            "circumferential_resection_margin": "--",
            "colon_polyps_history": "--",
            "figo_stage": "Stage IV",
            "hiv_positive": "--",
            "hpv_positive_type": "--",
            "hpv_status": "--",
            "ldh_level_at_diagnosis": "--",
            "ldh_normal_range_upper": "--",
            "lymph_nodes_positive": "--",
            "morphology": "8441/3",
            "new_event_anatomic_site": "--",
            "new_event_type": "--",
            "prior_malignancy": null,
            "prior_treatment": false,
            "site_of_resection_or_biopsy": "Ovary",
            "tissue_or_organ_of_origin": "Ovary",
            "tumor_stage": null
        },
        {
            "case_id": "67344504-63d7-11e8-bcf1-0a2705229b82",
            "case_submitter_id": "TCGA-24-1431",
            "project_submitter_id": "CPTAC-TCGA",
            "primary_site": "Ovary",
            "disease_type": "Ovarian Serous Cystadenocarcinoma",
            "demographic_id": "f6998567-7588-11e8-bcf1-0a2705229b82",
            "demographic_submitter_id": "TCGA-24-1431-DM",
            "race": "White",
            "ethnicity": null,
            "gender": "Female",
            "days_to_birth": -24758.0,
            "days_to_death": 583.0,
            "year_of_birth": 1932.0,
            "year_of_death": 2000.0,
            "vital_status": "Dead",
            "diagnosis_id": "ff2c0d02-70ca-11e8-bcf1-0a2705229b82",
            "diagnosis_submitter_id": "TCGA-24-1431-DX",
            "primary_diagnosis": "Serous cystadenocarcinoma, NOS",
            "age_at_diagnosis": 24758.0,
            "year_of_diagnosis": "1999",
            "days_to_hiv_diagnosis": "--",
            "days_to_last_follow_up": 583.0,
            "days_to_last_known_disease_status": null,
            "days_to_new_event": "--",
            "ajcc_pathologic_m": null,
            "ajcc_pathologic_n": null,
            "ajcc_pathologic_stage": null,
            "ajcc_pathologic_t": null,
            "circumferential_resection_margin": "--",
            "colon_polyps_history": "--",
            "figo_stage": "Stage IIIC",
            "hiv_positive": "--",
            "hpv_positive_type": "--",
            "hpv_status": "--",
            "ldh_level_at_diagnosis": "--",
            "ldh_normal_range_upper": "--",
            "lymph_nodes_positive": "--",
            "morphology": "8441/3",
            "new_event_anatomic_site": "--",
            "new_event_type": "--",
            "prior_malignancy": null,
            "prior_treatment": false,
            "site_of_resection_or_biopsy": "Ovary",
            "tissue_or_organ_of_origin": "Ovary",
            "tumor_stage": null
        },
        {
            "case_id": "7b889f56-63d7-11e8-bcf1-0a2705229b82",
            "case_submitter_id": "TCGA-24-1557",
            "project_submitter_id": "CPTAC-TCGA",
            "primary_site": "Ovary",
            "disease_type": "Ovarian Serous Cystadenocarcinoma",
            "demographic_id": "f69994ad-7588-11e8-bcf1-0a2705229b82",
            "demographic_submitter_id": "TCGA-24-1557-DM",
            "race": "White",
            "ethnicity": null,
            "gender": "Female",
            "days_to_birth": -17943.0,
            "days_to_death": 1213.0,
            "year_of_birth": 1951.0,
            "year_of_death": 2003.0,
            "vital_status": "Dead",
            "diagnosis_id": "ff2c3468-70ca-11e8-bcf1-0a2705229b82",
            "diagnosis_submitter_id": "TCGA-24-1557-DX",
            "primary_diagnosis": "Serous cystadenocarcinoma, NOS",
            "age_at_diagnosis": 17943.0,
            "year_of_diagnosis": "2000",
            "days_to_hiv_diagnosis": "--",
            "days_to_last_follow_up": 1213.0,
            "days_to_last_known_disease_status": null,
            "days_to_new_event": "--",
            "ajcc_pathologic_m": null,
            "ajcc_pathologic_n": null,
            "ajcc_pathologic_stage": null,
            "ajcc_pathologic_t": null,
            "circumferential_resection_margin": "--",
            "colon_polyps_history": "--",
            "figo_stage": "Stage IIIC",
            "hiv_positive": "--",
            "hpv_positive_type": "--",
            "hpv_status": "--",
            "ldh_level_at_diagnosis": "--",
            "ldh_normal_range_upper": "--",
            "lymph_nodes_positive": "--",
            "morphology": "8441/3",
            "new_event_anatomic_site": "--",
            "new_event_type": "--",
            "prior_malignancy": null,
            "prior_treatment": false,
            "site_of_resection_or_biopsy": "Ovary",
            "tissue_or_organ_of_origin": "Ovary",
            "tumor_stage": null
        },
        {
            "case_id": "8b0bd36f-63d7-11e8-bcf1-0a2705229b82",
            "case_submitter_id": "TCGA-24-2024",
            "project_submitter_id": "CPTAC-TCGA",
            "primary_site": "Ovary",
            "disease_type": "Ovarian Serous Cystadenocarcinoma",
            "demographic_id": "f69ba71a-7588-11e8-bcf1-0a2705229b82",
            "demographic_submitter_id": "TCGA-24-2024-DM",
            "race": "Black or African American",
            "ethnicity": null,
            "gender": "Female",
            "days_to_birth": -26476.0,
            "days_to_death": 1769.0,
            "year_of_birth": 1922.0,
            "year_of_death": 1998.0,
            "vital_status": "Dead",
            "diagnosis_id": "ff2f2838-70ca-11e8-bcf1-0a2705229b82",
            "diagnosis_submitter_id": "TCGA-24-2024-DX",
            "primary_diagnosis": "Serous cystadenocarcinoma, NOS",
            "age_at_diagnosis": 26476.0,
            "year_of_diagnosis": "1994",
            "days_to_hiv_diagnosis": "--",
            "days_to_last_follow_up": 1769.0,
            "days_to_last_known_disease_status": null,
            "days_to_new_event": "--",
            "ajcc_pathologic_m": null,
            "ajcc_pathologic_n": null,
            "ajcc_pathologic_stage": null,
            "ajcc_pathologic_t": null,
            "circumferential_resection_margin": "--",
            "colon_polyps_history": "--",
            "figo_stage": "Stage IIIC",
            "hiv_positive": "--",
            "hpv_positive_type": "--",
            "hpv_status": "--",
            "ldh_level_at_diagnosis": "--",
            "ldh_normal_range_upper": "--",
            "lymph_nodes_positive": "--",
            "morphology": "8441/3",
            "new_event_anatomic_site": "--",
            "new_event_type": "--",
            "prior_malignancy": null,
            "prior_treatment": false,
            "site_of_resection_or_biopsy": "Ovary",
            "tissue_or_organ_of_origin": "Ovary",
            "tumor_stage": null
        }
    ]
}